Osteologix to Present at 7^th Annual BIO Investor Forum

GLEN ALLEN, Va.--(BUSINESS WIRE)--Osteologix, Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO of Osteologix, Inc., will present a corporate overview on Thursday, October 30, at the 7^th Annual BIO Investor Forum in San Francisco. The presentation will take place at 3:45 p.m. PT at the Palace Hotel.

About Osteologix

Osteologix is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis, by developing innovative therapies. Its lead investigational product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.